An international survey on anastomotic stricture management after esophageal atresia repair: considerations and advisory statements

• Published in: Surgical endoscopy Vol. 35; no. 7; pp. 3653 - 3661
• Main Authors: ten Kate, Chantal A., Tambucci, Renato, Vlot, John, Spaander, Manon C. W., Gottrand, Frederic, Wijnen, Rene M. H., Dall’Oglio, Luigi
• Format: Journal Article
• Language: English
• Published: New York Springer US 01-07-2021; Springer Nature B.V; Springer Verlag (Germany)
• Subjects: Abdominal Surgery; Endoscopy; Esophagus; Gastroenterology; Gynecology; Hepatology; Life Sciences; Medicine; Medicine & Public Health; Nutrition; Pediatrics; Proctology; Questionnaires; Rare diseases; Surgery; Working groups; Esophageal atresia; Anastomotic strictures; Dilatation management
• ISSN: 0930-2794; 1432-2218
• DOI: 10.1007/s00464-020-07844-6

Background
Endoscopic dilatation is the first-line treatment of stricture formation after esophageal atresia (EA) repair. However, there is no consensus on how to perform these dilatation procedures which may lead to a large variation between centers, countries and doctor’s experience. This is the first cross-sectional study to provide an overview on differences in endoscopic dilatation treatment of pediatric anastomotic strictures worldwide.
Methods
An online questionnaire was sent to members of five pediatric medical networks, experienced in treating anastomotic strictures in children with EA. The main outcome was the difference in endoscopic dilatation procedures in various centers worldwide, including technical details, dilatation approach (routine or only in symptomatic patients), and adjuvant treatment options. Descriptive statistics were performed with SPSS.
Results
Responses from 115 centers from 32 countries worldwide were analyzed. The preferred approach was balloon dilatation (68%) with a guidewire (66%), performed by a pediatric gastroenterologist (
n
 = 103) or pediatric surgeon (
n
 = 48) in symptomatic patients (68%). In most centers, hydrostatic pressure was used for balloon dilatation. The insufflation duration was standardized in 59 centers with a median duration of 60 (range 5–300) seconds. The preferred first-line adjunctive treatments in case of recurrent strictures were intralesional steroids and topical mitomycin C, in respectively 47% and 31% of the centers.
Conclusions
We found a large variation in stricture management in children with EA, which confirms the current lack of consensus. International networks for rare diseases are required for harmonizing and comparing the procedures, for which we give several suggestions.